David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Meta Platforms (Facebook)
META
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
T-Mobile US
TMUS
|
+$416M |
| 5 |
Uber
UBER
|
+$350M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$547M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$490M |
| 3 |
Johnson & Johnson
JNJ
|
+$444M |
| 4 |
Apple
AAPL
|
+$435M |
| 5 |
Accenture
ACN
|
+$378M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.7% |
| 2 | Consumer Discretionary | 8.8% |
| 3 | Healthcare | 8.52% |
| 4 | Financials | 6% |
| 5 | Industrials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Occidental Petroleum
OXY
$58.4B
| $9.83M | 0.01% |
167,247
-1,923,239
| -92% | -$115M |
|
1252
Fastly Inc
FSLY
$3.66B
| $9.82M | 0.01% |
622,439
-688,262
| -53% | -$10.5M |
|
1253
Mettler-Toledo International
MTD
$28.1B
| $9.82M | 0.01% |
7,483
-4,770
| -39% | -$6.71M |
|
1254
CALL
Equinix
EQIX
$106B
| $9.8M | 0.01% |
+12,500
| New | +$9.15M |
|
1255
Exelixis
EXEL
$14.1B
| $9.79M | 0.01% |
512,349
-180,812
| -26% | -$3.49M |
|
1256
Pitney Bowes
PBI
$2.34B
| $9.79M | 0.01% |
2,765,147
-249,238
| -8% | -$864K |
|
1257
Factset
FDS
$10.5B
| $9.79M | 0.01% |
24,423
+20,694
| +555% | +$8.35M |
|
1258
Ironwood Pharmaceuticals
IRWD
$725M
| $9.78M | 0.01% |
918,998
+118,275
| +15% | +$1.27M |
|
1259
Darden Restaurants
DRI
$25B
| $9.76M | 0.01% |
58,430
-12,273
| -17% | -$1.93M |
|
1260
PUT
Cheniere Energy
LNG
$57.6B
| $9.71M | 0.01% |
63,700
-51,500
| -45% | -$7.62M |
|
1261
SI-BONE Inc
SIBN
$876M
| $9.69M | 0.01% |
+359,211
| New | +$8.76M |
|
|
PDCO
1262
DELISTED
Patterson Companies, Inc.
PDCO
| $9.69M | 0.01% |
291,273
+31,129
| +12% | +$858K |
|
1263
US Bancorp
USB
$97.2B
| $9.66M | 0.01% |
292,481
-1,639,221
| -85% | -$53M |
|
1264
CALL
Sunrun
RUN
$2.21B
| $9.66M | 0.01% |
540,800
-147,100
| -21% | -$2.74M |
|
|
CYBR
1265
DELISTED
CyberArk
CYBR
| $9.65M | 0.01% |
+61,747
| New | +$8.84M |
|
1266
PUT
Inspire Medical Systems
INSP
$1.77B
| $9.64M | 0.01% |
29,700
+9,700
| +49% | +$2.77M |
|
1267
Voya Financial
VOYA
$9.11B
| $9.64M | 0.01% |
134,371
-505,630
| -79% | -$36.3M |
|
1268
Genesco
GCO
$374M
| $9.63M | 0.01% |
384,736
+273,949
| +247% | +$7.93M |
|
1269
CALL
International Paper
IP
$21.7B
| $9.62M | 0.01% |
302,500
+2,500
| +0.8% | +$81.9K |
|
|
1270
PUT
International Paper
IP
$21.7B
| $9.62M | 0.01% |
302,500
+2,500
| +0.8% | +$81.9K |
|
|
AXON
1271
PUT
Axon Enterprise
AXON
$49.8B
| $9.62M | 0.01% |
49,300
+33,600
| +214% | +$6.96M |
|
1272
Ingevity
NGVT
$2.37B
| $9.62M | 0.01% |
165,324
-205,321
| -55% | -$12.3M |
|
1273
Pacific Biosciences
PACB
$472M
| $9.6M | 0.01% |
721,632
+106,381
| +17% | +$1.29M |
|
|
SPWR
1274
DELISTED
SunPower Corporation Common Stock
SPWR
| $9.56M | 0.01% |
975,831
+140,702
| +17% | +$1.64M |
|
|
MORF
1275
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $9.55M | 0.01% |
166,608
+106,592
| +178% | +$5.57M |
|
Similar funds
David Shaw's Q2 2023 Portfolio in Review
As of Q2 2023, David Shaw held 4,841 positions worth $97.9B, up 4.8% from $93.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $4.46B in Q2 2023, closing 639 positions and reducing 1,586 holdings. Its most notable exit was Shaw Communications Inc., an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Oracle worth $217M.
- David Shaw's largest Q2 2023 buy was Oracle: 1,825,762 shares worth $217M.
- David Shaw added most to NVIDIA in Q2 2023, an estimated $997M increase.
- David Shaw's biggest Q2 2023 reduction was Visa, cutting an estimated $547M.
- David Shaw fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $152M.
- David Shaw's ten largest holdings make up 12% of its $97.9B portfolio in Q2 2023.
- David Shaw opened 467 new positions and closed 639 in Q2 2023.
- David Shaw's portfolio value rose 4.8% quarter-over-quarter to $97.9B.
Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.